ClariTrial | Search Clinical Trials

Explore/C4 Therapeutics

Status

Phase

764 results for “C4 Therapeutics”

Page 1 of 51

Completed

Results posted

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Phase 1Asthma

GSK3511294PlaceboSalbutamol/albuterol

GlaxoSmithKline50 participants5 sites · Germany, United KingdomCompletes Jul 2019

Compare CT.gov Full analysis →

Completed

Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects

Phase 1Healthy

EYP001aPlacebo

Enyo Pharma80 participantsCompletes Mar 2017

Compare CT.gov Full analysis →

Completed

Results posted

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Phase 2Primary Biliary Cholangitis

Bezafibrate 100 mgBezafibrate 200 mgObeticholic Acid 5 mg+2 more

Intercept Pharmaceuticals72 participants26 sites · United States, Argentina, CanadaCompletes Sep 2025

Compare CT.gov Full analysis →

UNKNOWN

Transcranial Direct Current Stimulation Combined With Intermittent Oral to Esophageal Tube on Dysphagia

N/ACerebral Infarction

Comprehensive rehabilitation therapyIntermittent Oro-esophageal Tube FeedingTranscranial direct current stimulation

Zeng Changhao84 participants1 site · South KoreaCompletes Nov 2024

Compare CT.gov Full analysis →

Completed

tDCS to Increase Aerobic Performance in Runners

Phase 1Phase 2Athletic Performance

Transcranial Direct Current Stimulation (tDCS)

University of Liege53 participants1 site · BelgiumCompletes Apr 2023

Compare CT.gov Full analysis →

UNKNOWN

Manipulative and Massage Therapy in the Lower Thoracic and Cervical Spine in Subjects With Fibromyalgia Syndrome

N/AFibromyalgia

Manipulative and Massage TherapyExercise Program

Universidad de Almeria64 participants1 site · SpainCompletes Nov 2020

Compare CT.gov Full analysis →

Completed

Results posted

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Phase 2Warm Autoimmune Hemolytic Anemia (wAIHA)

ANX005

Annexon, Inc.7 participants4 sites · United States, Australia, AustriaCompletes Jan 2023

Compare CT.gov Full analysis →

Completed

A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)

Phase 1Acute Myeloid Leukemia

AtezolizumabGuadecitabine

Hoffmann-La Roche40 participants8 sites · United StatesCompletes Dec 2019

Compare CT.gov Full analysis →

Completed

Results posted

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

N/AChronic Kidney Failure

Vantive Health LLC33 participants2 sites · United StatesCompletes May 2008

Compare CT.gov Full analysis →

Active

Treatment of Bile Acid Diarrhoea With Atorvastatin

Phase 4Bile Acid DiarrheaBile Acid Malabsorption

AtorvastatinPlacebo

Asger Lund, MD20 participants1 site · DenmarkCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma

Phase 2Large B Cell Lymphoma

EpcoritamabEpcoritamab, tafasitamab and lenalidomide

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea80 participants15 sites · SpainCompletes Dec 2031

Compare CT.gov Full analysis →

Not Yet Recruiting

BCMA-CD19 cCAR T for the Treatment of Refractory Lupus

Phase 1Phase 2Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)

ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following cyclophosphamide-only lymphodepletion

iCell Gene Therapeutics20 participantsCompletes Dec 2028

Compare CT.gov Full analysis →

Completed

Results posted

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

Phase 2Systemic Lupus Erythematosus

BMS-986165Placebo

Bristol-Myers Squibb363 participants192 sites · United States, Argentina, AustraliaCompletes Jun 2021

Compare CT.gov Full analysis →

Not Yet Recruiting

Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)

N/ASjögren´s Syndrome

Central Hospital, Nancy, France150 participants1 site · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

Effects of Pain, Disability and Cervicokinesthesia After Cervical Manipulation

N/ANeck Pain

Right Cervical ManipulationLeft Cervical ManipulationSham Cervical Manipulation

Universidad Rey Juan Carlos55 participants1 site · SpainCompletes Nov 2016

Compare CT.gov Full analysis →

1–15 of 764

Explore/C4 Therapeutics

Status

Phase

764 results for “C4 Therapeutics”

Page 1 of 51

Completed

Results posted

Phase 1Asthma

GSK3511294PlaceboSalbutamol/albuterol

GlaxoSmithKline50 participants5 sites · Germany, United KingdomCompletes Jul 2019

Compare CT.gov Full analysis →

Completed

Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects

Phase 1Healthy

EYP001aPlacebo

Enyo Pharma80 participantsCompletes Mar 2017

Compare CT.gov Full analysis →

Completed

Results posted

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Phase 2Primary Biliary Cholangitis

Bezafibrate 100 mgBezafibrate 200 mgObeticholic Acid 5 mg+2 more

Intercept Pharmaceuticals72 participants26 sites · United States, Argentina, CanadaCompletes Sep 2025

Compare CT.gov Full analysis →

UNKNOWN

Transcranial Direct Current Stimulation Combined With Intermittent Oral to Esophageal Tube on Dysphagia

N/ACerebral Infarction

Comprehensive rehabilitation therapyIntermittent Oro-esophageal Tube FeedingTranscranial direct current stimulation

Zeng Changhao84 participants1 site · South KoreaCompletes Nov 2024

Compare CT.gov Full analysis →

Completed

tDCS to Increase Aerobic Performance in Runners

Phase 1Phase 2Athletic Performance

Transcranial Direct Current Stimulation (tDCS)

University of Liege53 participants1 site · BelgiumCompletes Apr 2023

Compare CT.gov Full analysis →

UNKNOWN

Manipulative and Massage Therapy in the Lower Thoracic and Cervical Spine in Subjects With Fibromyalgia Syndrome

N/AFibromyalgia

Manipulative and Massage TherapyExercise Program

Universidad de Almeria64 participants1 site · SpainCompletes Nov 2020

Compare CT.gov Full analysis →

Completed

Results posted

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Phase 2Warm Autoimmune Hemolytic Anemia (wAIHA)

ANX005

Annexon, Inc.7 participants4 sites · United States, Australia, AustriaCompletes Jan 2023

Compare CT.gov Full analysis →

Completed

A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)

Phase 1Acute Myeloid Leukemia

AtezolizumabGuadecitabine

Hoffmann-La Roche40 participants8 sites · United StatesCompletes Dec 2019

Compare CT.gov Full analysis →

Completed

Results posted

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

N/AChronic Kidney Failure

Vantive Health LLC33 participants2 sites · United StatesCompletes May 2008

Compare CT.gov Full analysis →

Active

Treatment of Bile Acid Diarrhoea With Atorvastatin

Phase 4Bile Acid DiarrheaBile Acid Malabsorption

AtorvastatinPlacebo

Asger Lund, MD20 participants1 site · DenmarkCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma

Phase 2Large B Cell Lymphoma

EpcoritamabEpcoritamab, tafasitamab and lenalidomide

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea80 participants15 sites · SpainCompletes Dec 2031

Compare CT.gov Full analysis →

Not Yet Recruiting

BCMA-CD19 cCAR T for the Treatment of Refractory Lupus

Phase 1Phase 2Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)

ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following cyclophosphamide-only lymphodepletion

iCell Gene Therapeutics20 participantsCompletes Dec 2028

Compare CT.gov Full analysis →

Completed

Results posted

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

Phase 2Systemic Lupus Erythematosus

BMS-986165Placebo

Bristol-Myers Squibb363 participants192 sites · United States, Argentina, AustraliaCompletes Jun 2021

Compare CT.gov Full analysis →

Not Yet Recruiting

Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)

N/ASjögren´s Syndrome

Central Hospital, Nancy, France150 participants1 site · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

Effects of Pain, Disability and Cervicokinesthesia After Cervical Manipulation

N/ANeck Pain

Right Cervical ManipulationLeft Cervical ManipulationSham Cervical Manipulation

Universidad Rey Juan Carlos55 participants1 site · SpainCompletes Nov 2016

Compare CT.gov Full analysis →

1–15 of 764